FUR-31447-09394
2 vaccinations
6 coded responses
23 check-ins
6 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 46-50
- ZIP prefix
- 721 / AR
- Registered
- 2021-04-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
2C6-99157-21955
Child or adolescent in my care · Female · 2022-05-08
Timeline
-
2021-04-19
Registered in v-safe
-
2021-04-19
Dose 1 — Pfizer-BioNTech
-
2021-04-19
Health check-in — day 0, dose 1Feeling: Good · Site: Itching · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-21
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Muscle or body achesAdult check-in
-
2021-04-22
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Muscle or body achesAdult check-in
-
2021-04-24
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Muscle or body achesAdult check-in
-
2021-04-25
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Muscle or body achesAdult check-in
- 2021-04-26
- 2021-05-03
-
2021-05-10
Dose 2 — Pfizer-BioNTech
-
2021-05-10
Survey response — day 0, dose 2MedDRA: Brain fog, Disturbance in attention — Feeling: Poor · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workFree text: Inability to focus mentally, cloudy-headedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-11
Survey response — days 1–6 daily, dose 2MedDRA: Ear disorder, Incoherent — Feeling: Poor · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Ear imbalance and lack of mental clarityMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-05-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-05-14
- 2021-05-15
- 2021-05-16
- 2021-05-17
-
2021-05-24
Survey response — day 14, dose 2MedDRA: Injection site pain — Feeling: GoodFree text: Arm pain at second injection site. Started two days ago, each day incrementally more than the previous day.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-31
-
2021-06-07
Survey response — day 28, dose 2MedDRA: Fatigue, Heart rate increased — Feeling: Poor · Be unable to work, Be unable to do your normal daily activitiesFree text: Resting heart rate increase, extreme fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-14
Survey response — day 35, dose 2MedDRA: Injection site discomfort, Injection site pain — Feeling: GoodFree text: Second Injection site continues to cause occasional discomfort, bordering on a lower threshold of pain, 3 on a scale of 1-10. Always at the same place.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-21
Survey response — day 42, dose 2MedDRA: Injection site discomfort — Feeling: Good · Be unable to do your normal daily activitiesFree text: Increase in sensitivity of injection site and spreading of discomfort from that location up and down the arm.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-11
- 2021-11-08
- 2022-05-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-19 | Pfizer-BioNTech | |
| 2 | 2021-05-10 | Pfizer-BioNTech |
Free text
Release 8 — day 0, dose 2
Systemic reaction (other): Inability to focus mentally, cloudy-headed
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Ear imbalance and lack of mental clarity
Release 8 — day 14, dose 2
Symptoms: Arm pain at second injection site. Started two days ago, each day incrementally more than the previous day.
Release 8 — day 28, dose 2
Symptoms: Resting heart rate increase, extreme fatigue
Release 9 — day 35, dose 2
Symptoms: Second Injection site continues to cause occasional discomfort, bordering on a lower threshold of pain, 3 on a scale of 1-10. Always at the same place.
Release 9 — day 42, dose 2
Symptoms: Increase in sensitivity of injection site and spreading of discomfort from that location up and down the arm.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Heart rate increased | ✓ | ✓ | ✓ |
| SD | Injection site discomfort | ✓ | ✓ | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Brain fog | ✓ | ✓ | ✓ |
| SRO | Disturbance in attention | ✓ | ✓ | ✓ |
| SRO | Ear disorder | ✓ | ✓ | ✓ |
| SRO | Incoherent | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release